BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 29020709)

  • 1. AbsorbaSeal™ Vascular Closure Device: A Novel Device for Hemostasis Following Interventional Peripheral Vascular Procedures.
    Benham E; Deloose K; Callaert J; Bosiers M; Cox T; Lincourt A; Heniford BT
    Surg Technol Int; 2017 Oct; 31():93-99. PubMed ID: 29020709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AbsorbaSeal™ 5.6.7F vascular closure device: A good laboratory practice chronic study evaluating safety and efficacy in a healthy porcine model.
    Ayuso SA; Shipp RC; Aladegbami BG; Farquharson D; Lawson D; Bassett R
    Vascular; 2022 Oct; 30(5):934-942. PubMed ID: 34459306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systematic Review of Randomized Controlled Trials Comparing Manual Compression to Vascular Closure Devices for Diagnostic and Therapeutic Arterial Procedures.
    Cox T; Blair L; Huntington C; Lincourt A; Sing R; Heniford BT
    Surg Technol Int; 2015 Nov; 27():32-44. PubMed ID: 26680377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized comparison of a novel bioabsorbable vascular closure device versus manual compression in the achievement of hemostasis after percutaneous femoral procedures: the ECLIPSE (Ensure's Vascular Closure Device Speeds Hemostasis Trial).
    Wong SC; Bachinsky W; Cambier P; Stoler R; Aji J; Rogers JH; Hermiller J; Nair R; Hutman H; Wang H;
    JACC Cardiovasc Interv; 2009 Aug; 2(8):785-93. PubMed ID: 19695549
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A multicenter randomized trial comparing the effectiveness and safety of a novel vascular closure device to manual compression in anticoagulated patients undergoing percutaneous transfemoral procedures: The CELT ACD trial.
    Wong SC; Laule M; Turi Z; Sanad W; Crowley J; Degen H; Bennett K; Coleman JE; Bergman G
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):756-765. PubMed ID: 28296003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioseal VIP® vs. StarClose SE® closure devices: a comparative analysis in non-cardiological procedures.
    Lucatelli P; Fanelli F; Cannavale A; Corona M; Cirelli C; D'Adamo A; Salvatori FM; Catalano C
    J Cardiovasc Surg (Torino); 2017 Feb; 58(1):80-86. PubMed ID: 24309473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mynx Vascular Closure Device in Arterial Endovascular Procedures.
    Scott MC; Spencer HJ; Ali AT; Moursi MM; Escobar GA; Lyons LC; Smeds MR
    Ann Vasc Surg; 2018 Jan; 46():112-117. PubMed ID: 28546043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the boomerang wire vascular access management system versus manual compression alone during percutaneous diagnostic and interventional cardiovascular procedures: The boomerang™ wire vascular access management trial II.
    Goswami NJ; Smalling RG; Sinha S; Gammon RS; Ramaiah VG
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):75-81. PubMed ID: 25599884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FemoSeal
    Gabrielli R; Rosati MS; Millarelli M; Dante A; Maiorano M; Musilli A; Chiappa R; Ventura M
    Ann Vasc Surg; 2018 Aug; 51():18-24. PubMed ID: 29678650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simplified swift and safe vascular closure device deployment without a local arteriogram: Single center experience in 2074 consecutive patients.
    Manolis AS; Georgiopoulos G; Stalikas D; Koulouris S
    Indian Heart J; 2016; 68(4):529-38. PubMed ID: 27543479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CLOSER trial: a multi-center study on the clinical safety and effectiveness of Closer
    Wong SC; Gammon R; Bachinsky W; O'Shaughnessy C; Leimbach W; Bernardo N; Cavros N; Jaff MR; Liu PY; Bergman G
    Catheter Cardiovasc Interv; 2017 Nov; 90(5):798-805. PubMed ID: 28833996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of manual compression and vascular hemostasis devices after coronary angiography or percutaneous coronary intervention through femoral artery access: A meta-analysis of randomized controlled trials.
    Dahal K; Rijal J; Shahukhal R; Sharma S; Watti H; Azrin M; Katikaneni P; Jimenez E; Tandon N; Modi K; Lee J
    Cardiovasc Revasc Med; 2018 Mar; 19(2):151-162. PubMed ID: 28941744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. First-in-man experience with a new 7F vascular closure device (EXOSEAL™): the 7F ECLIPSE study.
    Wiemer M; Langer C; Fichtlscherer S; Firschke C; Hofbauer F; Lins M; Haude M; Debèfve C; Stoll HP; Hanefeld C
    J Interv Cardiol; 2012 Oct; 25(5):518-25. PubMed ID: 22762417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the Angioseal device for femoral artery closure.
    Abando A; Hood D; Weaver F; Katz S
    J Vasc Surg; 2004 Aug; 40(2):287-90. PubMed ID: 15297822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single Angio-Seal vascular closure device for transfemoral access exceeding 8F.
    Frenzel F; Fries P; Shayesteh-Kheslat R; Buecker A; Massmann A
    J Cardiol; 2020 Aug; 76(2):211-216. PubMed ID: 32402666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices.
    Duffin DC; Muhlestein JB; Allisson SB; Horne BD; Fowles RE; Sorensen SG; Revenaugh JR; Bair TL; Lappe DL
    J Invasive Cardiol; 2001 May; 13(5):354-62. PubMed ID: 11385148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of vascular closure devices vs manual compression after femoral artery puncture: the ISAR-CLOSURE randomized clinical trial.
    Schulz-Schüpke S; Helde S; Gewalt S; Ibrahim T; Linhardt M; Haas K; Hoppe K; Böttiger C; Groha P; Bradaric C; Schmidt R; Bott-Flügel L; Ott I; Goedel J; Byrne RA; Schneider S; Burgdorf C; Morath T; Kufner S; Joner M; Cassese S; Hoppmann P; Hengstenberg C; Pache J; Fusaro M; Massberg S; Mehilli J; Schunkert H; Laugwitz KL; Kastrati A;
    JAMA; 2014 Nov; 312(19):1981-7. PubMed ID: 25399273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of using vascular closure devices for hemostasis on sheath removal after a transfemoral artery percutaneous coronary intervention.
    Su SF; Chang MY; Wu MS; Liao YC
    Jpn J Nurs Sci; 2019 Apr; 16(2):172-183. PubMed ID: 30044037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Access site complications are uncommon with vascular closure devices or manual compression after lower extremity revascularization.
    Cheng TW; Farber A; King EG; Levin SR; Arinze N; Malas MB; Eslami MH; Garg K; Rybin D; Siracuse JJ
    J Vasc Surg; 2022 Sep; 76(3):788-796.e2. PubMed ID: 35618194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center comparison of the efficacy and complications of arterial vascular closure devices in interventional radiology.
    Elmasri MA; Kee ST; Moriarty JM; Gomes A; Lee EW; McWilliams JP
    J Vasc Access; 2017 Jul; 18(4):339-344. PubMed ID: 28665467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.